Cetuximab
- Biologic
- ERBITUX
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Cetuximab: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store vials under refrigeration at 2° C to 8° C (36° F to 46° F).
- Freezing
- Do not freeze
Label statement
Do not freeze or shake.
- Room temperature
- up to 8 hours at or below 8°C
Label statement
Discard any remaining solution in the infusion container after 8 hours at controlled room temperature or after 12 hours at 2° C to 8° C.
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (5)
- Store vials under refrigeration at 2° C to 8° C (36° F to 46° F).
- Do not freeze or shake.
- Increased particulate formation may occur at temperatures at or below 0° C (32° F).
- Discard any remaining solution in the infusion container after 8 hours at controlled room temperature or after 12 hours at 2° C to 8° C.
- Discard any unused portion of the vial.
FDA label version 58, effective April 16, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.